« previous next »
Pages: [1]

Author Topic: (Abst.) PML in Tecfidera-treated MS patients  (Read 56 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9480
  • MS diagnosed 1980
  • Location: Pacific Northwest
PML outcomes in MS patients treated with dimethyl fumarate
« on: November 13, 2022, 09:41:08 pm »

Some Biogen researchers have published a report on MS patients being treated with dimethyl fumarate who developed PML.


From Multiple Sclerosis Journal (November 10, 2022)--"Progressive multifocal leucoencephalopathy outcomes in patients with multiple sclerosis treated with dimethyl fumarate":


https://journals.sagepub.com/doi/full/10.1177/20552173221132469
« Last Edit: November 13, 2022, 09:48:09 pm by agate »
Report to moderator   Logged
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics